Posner JBNeurologic complications of cancerPhiladelphia. FADavis Company; 1995.
2.
Elrington GM , Murray NM, Spiro SG, Newsom-Davis J.Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patientsJ Neurol Neurosurg Psychiatry1991;54:764-767.
3.
Henson RA, Urich H.Cortical cerebellar degeneration. In: Henson RA, Urich H, editors. Cancer and the nervous systemOxford, UK: Blackwell Scientific Publications; 1982. p. 314-345.
4.
Lang B., Newsom-Davis J.Immunopathology of the Lambert-Eaton myasthemc syndromeSemin Immunopathol1995;17:3-15.
5.
Lindstrom JD , Shelton A., Fujii Y.Myasthema gravisAdv Immunol1988;42:233-284.
6.
Newsom-Davis J., Murray NMPlasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthemc syndromeNeurology1984;34:480-485.
7.
Drachman DBMyasthenia gravisN Eng J Med1994 ;330:1797-1810.
8.
Sillevis-Smitt PA, Manley GT, Posner JBImmunization with the paraneoplastic antigen HuD does not cause neurologic disease in miceNeurology1995;45:1873-1878.
9.
Tanaka K., Tanaka M., Onodera O., Igarashi S., Miyatake T., Tsuji S.Passive transfer and active immunization with the recombinant leucine-zipper (Yo) protein as an attempt to establish an animal model of paraneoplastic cerebellar degenerationJ Neurol Sci1994 ;127:153-158.
10.
Dalmau J., Furneaux HM, Gralla RJ, Kris MG, Posner JBDetection of the anti-Hu antibody in the serum of patients with small cell lung cancer: A quantitative western blot analysisAnn Neurol1990;27:544-552.
11.
Peterson K. , Rosenblum MK, Kotanides H., Posner JBParaneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patientsNeurology1992;42:1931-1937.
12.
Luque FA, Furneaux HM, Ferziger R., et al.Anti-Ri: An antibody associated with paraneoplastic opsoclonus and breast cancerAnn Neurol1991;29:241-251.
13.
Furneaux HM , Reich L., Posner JBAutoantibody synthesis in the central nervous system of patients with paraneoplastic syndromesNeurology1990;40:1085-1091.
14.
Graus F., Segurado OG, Tolosa E.Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degenerationActa Neurol Scand1988;78:210-213.
15.
Anderson NE , Rosenblum MK, Graus F., Wiley RG, Posner JBAutoantibodies in paraneoplastic syndromes associated with small cell lung cancerNeurology1988;38:1391-1398.
16.
Graus F., Ribalta T., Campo E., Monforte R., Urbano A., Rozman C.Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitisNeurology1990;40:219-22.
17.
Verschuuren J., Chuang L., Rosenblum MK, et al.Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo associated paraneoplastic cerebellar degenerationActa Neuropathol1996;91:519-525.
18.
Dalmau J., Furneaux HM, Rosenblum MK, Graus F., Posner JBDetection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathyNeurology1991;41:1757-1764.
19.
Jean WC, Dalmau J., Ho A., Posner JBAnalysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu associated paraneoplastic encephalomyelitisNeurology1994; 44:140-147.
20.
Dalmau J., Furneaux HM, Cordon-Cardo C., Posner JBThe expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissuesAm J Pathol1992;141:881-886.
21.
Dalmau J., Graus F., Cheung NK, et al.Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancerCancer1995;75:99-109.
22.
Liu S., Mezrich J., Berk J., Federici M., Dalmau J., Posner JBExpression of Purkinje-cell antigens in ovarian tumor, and presence of anti-Purkinje cell antibodies in the serum of patients without paraneoplastic cerebellar degeneration [abstract]. Neurology1995; 45(Suppl 4):A228-A229.
23.
Nobile-Orazio E., Manfredini E., Carpo M., et al.Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathyAnn Neurol1994; 36:416-424.
24.
Vallat JM, De Mascarel HA, Bordessoule D., et al.Non-Hodgkin's malignant lymphomas and peripheral neuropathies—13 casesBrain1995;118:1233-1245.
Denny-Brown D.Primary sensory neuropathy with muscular changes associated with carcinomaJ Neurol Neurosurg Psychiatry1948;11:73-87.
27.
Brain WR, Daniel PM, Greenfield JGSubacute cortical cerebellar degeneration and its relation to carcinomaJ Neurol Neurosurg Psychiatry1951;14:59-75.
28.
Henson RA, Hoffman HL, Unch H.Encephalomyelitis with carcinomaBrain1965 ;88:449-64.
29.
Elmqvist D. , Lambert EHDetailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinomaMayo Clin Proc1968; 43:689-713.
30.
Mancall EL, Rosales RKNecrotizing myelopathy associated with visceral carcinomaBrain1964;87:639-659.
31.
Dalmau J., Graus F., Rosenblum MK, Posner JBAnti-Hu associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patientsMedicine1992;71:59-72.
32.
Mason WP, Graus F., Lang B., et al.Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndromeBrain1997;120:1279-1300.
33.
Graus F., Dalmau J., Valldeoriola F., et al.Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's diseaseJ Neuroimmunol1997;74:55-61.
34.
Graus F., Dalmau J., Rene R., et al.Anti-Hu antibodies in patients with small cell lung cancer: association with complete response to therapy and improved survivalJ Clin Oncol1997;15:2866-2872.
35.
Hetzel DJ, Stanhope R., O'Neill BP, Lennon VAGynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volumeMayo Clin Proc1990;65:1558-1563.
36.
Dalmau J., Graus F.Paraneoplastic syndromes of the nervous system In: Black PMcL, Loeffler JS, editors. Cancer of the nervous system.Oxford, UK: Blackwell Scientific Publications; 1997. p. 674-700.
37.
Dirr LY, Elster AD, Donofrio PD, Smith M.Evolution of brain MRI abnormalities in limbic encephalitisNeurology1990;40: 1304-1306.
38.
Glantz MJ, Biran H., Myers ME, Gockerman JP, Friedberg MHThe radiographic diagnosis and treatment of paraneoplastic central nervous system diseaseCancer1994;73:168-175.
39.
Alamowitch S. , Graus F., Uchuya M., Reñé R., Bescansa E., Delattre J-Y.Limbic encephalitis and small cell lung cancer: clinical and immunological featuresBrain1997;120:923-928.
40.
Ito H., Sayama S., Ine S., et al.Antmeuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infectionNeurology1994;44:1506-1507.
41.
Saiz A., Arpa J., Sagasta A., et al.Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocnne autoimmumtyNeurology1997;49.1026-1030.
42.
Brashear HR , Greenlee JE, Jaeckle KA, Rose JWAnticerebellar antibodies in neurologically normal patients with ovarian neoplasmNeurology1989;39:1605-1609.
43.
O'Neill JH, Murray Nmf, Newsom-Davis J.The Lambert-Eaton myasthemc syndrome A review of 50 casesBrain1988;111:577-596.
44.
Motomura M. , Lang B., Johnston I., Palace J., Vincent A., Newsom-Davis J.Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthemc syndromeJ Neurol Sci1997;147:35-42
45.
Chalk CH, Murray NM, Newsom-Davis J., O'Neill JH, Spiro SGResponse of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinomaNeurology1990;40: 1552-1556
46.
Barn PG, Motomura M., Newsom-Davis J., et al.Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndromeNeurology1996;47:678-683.
47.
Chalk CH, Windebank AJ, Kimmel DW, et al.The distinctive clinical features of paraneoplastic sensory neuronopathyCan J Neurol Sci1992;19:346-351.
48.
Cohn SL, Salwen H., Herst CV, et al.Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonusCancer1988;62:723-726.
49.
Connolly AM , Pestronk A., Mehta S., Pranzatelli MR, Noetzel MJSerum autoantibodies in childhood opsoclonus-myoclonus syndrome : an analysis of antigenic targets in neural tissuesJ Pediatncs1997;130:878-884.
50.
Russo C., Cohn SL, Petruzzi MJ, Alarcon PALong-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the pediatric oncology groupMed Pediatr Oncol1997;28:284-288.
51.
Anderson NE , Budde-Steffen C., Rosenblum MK, et al.Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer : A distinct paraneoplastic syndromeMedicine1988;67:100-109.
52.
Casado JL, Gil-Peralta A., Graus F., Arenas C., Lopez JM, Alberca R.Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidityNeurology1994;44:1521-1522.
53.
Dropcho EJ, Kline LB, Riser J.Antineuronal (anti-Ri) autoantibodies in a patient with steroid-responsive opsoclonus myoclonusNeurology1993;43:207-211.
54.
Shilhto P., Molenaar PC, Vincent A., et al.Acquired neuromyotoma : evidence for autoantibodies directed against K+ channels of peripheral nervesAnn Neurol1995;38:714-722.
